Please set your featured image
Renfrew Group International Appointed to Design OMD Breath Ketone Analysis Platform
Oxford Medical Diagnostics
Oxford Medical Diagnostics (OMD), a leading developer of advanced proprietary methods of analysing volatile organic compounds (VOCs) in breath, has contracted Renfrew Group International (RGi) for the industrial design of a portable breath analysis platform based upon OMD’s prototype device.
See here to read more on this release.